Abstract:Astrocytes are key players in maintaining central nervous system (CNS) homeostasis. Proper control of cellular bioenergetics is essential for this, and poor control of astrocyte bioenergetics may underlie many CNS conditions. We hypothesized that translocator protein 18 kDa (TSPO) regulates the metabolism of astrocytes and thus serves as a therapeutic target. In two models, TSPO deficiency reduced bioenergetic rates and lactate release, while promoting bioenergetic resistance to glucose withdrawal and fatty acid oxidation (FAO). Following lipopolysaccharide (LPS) stimulation, TSPO deficient astrocytes showed no change in activation of inflammatory pathways but delayed tumor necrosis factor (TNF) release. We think this warrants further investigation into TSPO function in astrocytes, and may present a promising therapeutic target. Schematic created by the authors with https://www.biorender.com. The mitochondrial translocator protein 18 kDa (TSPO) has been linked to functions from steroidogenesis to regulation of cellular metabolism and is an attractive therapeutic target for chronic CNS inflammation. Studies in Leydig cells and microglia indicate that TSPO function may vary between cells depending on their specialized roles. Astrocytes are critical for providing trophic and metabolic support in the brain. Recent work has highlighted that TSPO expression increases in astrocytes under inflamed conditions and may drive astrocyte reactivity. Relatively little is known about the role TSPO plays in regulating astrocyte metabolism and whether this protein is involved in immunometabolic processes in these cells. Using TSPO‐deficient (TSPO−/−) mouse primary astrocytes in vitro (MPAs) and a human astrocytoma cell line (U373 cells), we performed extracellular metabolic flux analyses. We found that TSPO deficiency reduced basal cellular respiration and attenuated the bioenergetic response to glucopenia. Fatty acid oxidation was increased, and lactate production was reduced in TSPO−/− MPAs and U373 cells. Co‐immunoprecipitation studies revealed that TSPO forms a complex with carnitine palmitoyltransferase 1a in U373 and MPAs, presenting a mechanism wherein TSPO may regulate FAO in these cells. Compared to TSPO+/+ cells, in TSPO−/− MPAs we observed attenuated tumor necrosis factor release following 3 h lipopolysaccharide (LPS) stimulation, which was enhanced at 24 h post‐LPS stimulation. Together these data suggest that while TSPO acts as a regulator of metabolic flexibility, TSPO deficiency does not appear to modulate the metabolic response of MPAs to inflammation, at least in response to the model used in this study.

Global Deletion Of Tspo Does Not Affect The Viability And Gene Expression Profile

Dysregulation of lipid metabolism in the liver of Tspo knockout mice

Functional gains in energy and cell metabolism after TSPO gene insertion

History of Tspo deletion and induction in vivo : Phenotypic outcomes under physiological and pathological situations

CRISPR-Cas9 Mediated TSPO Gene Knockout alters Respiration and Cellular Metabolism in Human Primary Microglia Cells

Deletion of TSPO Causes Dysregulation of Cholesterol Metabolism in Mouse Retina

Impact of Translocator Protein 18 kDa (TSPO) Deficiency on Mitochondrial Function and the Inflammatory State of Human C20 Microglia Cells

Translocator Protein (18 Kda): A Promising Therapeutic Target and Diagnostic Tool for Cardiovascular Diseases

Mitochondrial Translocator Protein (TSPO) Is a Regulator of Fatty Acid Metabolism

A Comprehensive Functional Investigation of the Human Translocator Protein 18 kDa (TSPO) in a Novel Human Neuronal Cell Knockout Model

TSPO Deficiency Exacerbates GSDMD-Mediated Macrophage Pyroptosis in Inflammatory Bowel Disease

[Down-Regulation of TSPO Expression Doesn't Affect the Productions of TNF-α, IL-1β and IL-6 in LPS-stimulated BV-2 Microglia].

Preservation of TSPO by chronic intermittent hypobaric hypoxia confers antiarrhythmic activity.

Downregulation of TSPO Expression Inhibits Oxidative Stress and Maintains Mitochondrial Homeostasis in Cardiomyocytes Subjected to Anoxia/reoxygenation Injury.

TSPO deficiency exacerbates acute lung injury via NLRP3 inflammasome-mediated pyroptosis

Regulation of astrocyte metabolism by mitochondrial translocator protein 18 kDa

TSPO is a Novel Biomarker for Prognosis That Regulates Cell Proliferation Through Influencing Mitochondrial Functions in HCC

TSPO deficiency accelerates amyloid pathology and neuroinflammation by impairing microglial phagocytosis

Disruption of Transient Receptor Potential Melastatin 2 Attenuate Lipopolysaccharide-Induced Heme Oxygenase-1 Expression in Mouse Macrophages Through P38 Mitogen-Activated Protein Kinase (P5202)

TSPO knockdown attenuates OGD/R-induced neuroinflammation and neural apoptosis by decreasing NLRP3 inflammasome activity through PPARγ pathway

Disruption of transient receptor potential melastatin 2 attenuate lipopolysaccharide-induced heme oxygenase-1 expression in mouse macrophages through p38 mitogen-activated protein kinase